• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Homeopathy effects in patients during oncological treatment: a systematic review
CONCLUSIONS: For homeopathy, there is neither a scientifically based hypothesis of its mode of action nor conclusive evidence from clinical studies in cancer care.PMID:35731274 | DOI:10.1007/s00432-022-04054-6
Source: Clinical Genitourinary Cancer - June 22, 2022 Category: Cancer & Oncology Authors: Anna Wagenknecht Jennifer D örfler Maren Freuding Lena Josfeld Jutta Huebner Source Type: research

Determinants of use of oral complementary-alternative medicine among women with early breast cancer:  a focus on cancer-related fatigue
ConclusionOne-in-four patients reported use of OCAM. More severe CRF was consistently associated with its use. Moreover, older, better educated, wealthier, more anxious women, and those receiving chemotherapy seemed more prone to use OCAM. Characterizing profiles of BC patients more frequently resorting to OCAM may help deliver targeted information about its benefits and potential risks.
Source: Breast Cancer Research and Treatment - September 24, 2021 Category: Cancer & Oncology Source Type: research

A French survey on the resort of oral alternative complementary medicines used in children with cancer.
CONCLUSIONS: The use of oral CAM in this survey was common. For most parents, this use was effective and appreciated because they generated fewer side effects than conventional treatments. However, doctors were not systematically informed of this use. This is problematic because some CAM such as herbal supplements could potentially cause interactions with cancer treatments. More information about CAM is necessary in pediatric onco-hematology. PMID: 26387822 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - September 17, 2015 Category: Cancer & Oncology Authors: Philibert C, Hoegy D, Philippe M, Marec-Bérard P, Bleyzac N Tags: Bull Cancer Source Type: research

Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer.
CONCLUSION: Some patients treated with Ruta graveolens 9c had a transitory improvement in QoL, but the effectiveness of this treatment remains to be confirmed in further studies. PMID: 25439039 [PubMed - in process]
Source: Homeopathy - October 1, 2014 Category: Complementary Medicine Authors: Freyer G, You B, Villet S, Tartas S, Fournel-Federico C, Trillet-Lenoir V, Hamizi S, Colomban O, Chavernoz N, Falandry C Tags: Homeopathy Source Type: research